2562329-13-7
Chemical Structure
(S)-Cdc7-IN-18
- CAS No.: 2562329-13-7
- Formula:C19H21N5OS
- Molecular Weight:367.47
IUPAC Name: (S)-8-(quinuclidin-2-yl)-2,4,5,6-tetrahydropyrazolo[4'',3'':3',4']cyclohepta[1',2':4,5]thieno[3,2-d]pyrimidin-10(7H)-one
InChIKey: MJWWMBBHELJWLE-AWEZNQCLSA-N
SMILES: O=C1C2=C(NC([C@@]3([H])N4CCC(CC4)C3)=N1)C5=C(C6=CNN=C6CCC5)S2
Biological Activity: (S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(S)-Cdc7-IN-18 | (S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
